Market closed

Agilent/$A

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Agilent

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Ticker

$A
Sector
Health Care

Trading on

NYSE

Industry

Life Sciences Tools & Services
Headquarters
Santa Clara, United States

Employees

17,900
Website
www.agilent.com

Agilent Metrics

BasicAdvanced
$41B
32.04
$4.43
1.06
$0.94
0.70%

$41B

1.06

$155.35

$124.16

1.5M

$0.94

2.089

1.478

56.714

57.477

21.26%

16.08%

8.54%

21.95%

32.043

6.323

6.86

46.32

29.982

0.67%

0.70%

-4.73%

5.73%

1.00%

3.98%

6.75%

What the Analysts think about Agilent

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Agilent stock.

Agilent Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Agilent Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Agilent News

AllArticlesVideos
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire·4 weeks ago
Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics

Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics

CNBC Television·4 weeks ago
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification

Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification

Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $A

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jan22
Agilent
Dividend·Payment
$0.248
Per share

FAQs

What’s the current market cap for Agilent stock?

Agilent (A) has a market cap of $41B as of January 15, 2025.

What is the P/E ratio for Agilent stock?

The price to earnings (P/E) ratio for Agilent (A) stock is 32.04 as of January 15, 2025.

Does Agilent stock pay dividends?

Yes, the Agilent (A) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.944 and the yield is 0.7%. Agilent has a payout ratio of 21.26% on a trailing twelve-month basis.

When is the next Agilent dividend payment date?

The next Agilent (A) dividend payment is scheduled for January 22, 2025.

What is the beta indicator for Agilent?

Agilent (A) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.